We analysed the secretome of VAT and SAT based on the obesity status of the patient and found significantly higher levels of bFGF, Eotaxin-3, and TNF-α secreted from the VAT of obese patients than from that of non-obese patients. This evidence concerns the gene FGF2 and obesity disorder.